NCIt definition : An orally bioavailable pan inhibitor of human fibroblast growth factor receptors (FGFRs)
with potential antiangiogenic and antineoplastic activities. Infigratinib selectively
binds to and inhibits the activities of FGFRs, which may result in the inhibition
of tumor angiogenesis and tumor cell proliferation, and the induction of tumor cell
death. FGFRs are a family of receptor tyrosine kinases which may be upregulated in
various tumor cell types and may be involved in tumor cell differentiation and proliferation,
tumor angiogenesis, and tumor cell survival.;
https://presse.inserm.fr/un-nouveau-traitement-entre-en-essai-clinique-chez-un-premier-enfant-achondroplase-en-france/42645 2021 false false false France French scientific and technical information achondroplasia clinical trials as topic child france Infigratinib phenylurea compounds pyrimidines receptor, fibroblast growth factor, type 1 infigratinib